Diagnosis and treatments of Hashimoto's encephalopathy

Clinical Neurology

Volumn 52, Issue 11, 2012, Pages 1240-1242

  Yoneda, Makoto ^a  

^a UNIVERSITY OF FUKUI HOSPITAL   (Japan)

Author keywords

Autoantibodies; Clinical features; Hashimoto's encephalopathy; Immunotherapy

Indexed keywords

ALPHA ENOLASE; IMMUNOGLOBULIN; STEROID;

ATAXIA; CEREBELLAR ATAXIA; CLINICAL FEATURE; CONFERENCE PAPER; CONSCIOUSNESS DISORDER; CREUTZFELDT JAKOB DISEASE; DEMENTIA; ELECTROENCEPHALOGRAM; HASHIMOTO ENCEPHALOPATHY; HUMAN; INVOLUNTARY MOVEMENT; MAJOR CLINICAL STUDY; MYOCLONUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC NEUROPATHY; PHENOTYPE; PLASMAPHERESIS; PSYCHOSIS; SEIZURE; STEROID THERAPY; TREMOR;

BRAIN DISEASES; HASHIMOTO DISEASE; HUMANS;

EID: 84877685867     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.52.1240     Document Type: Conference Paper

References (8)

1. Shaw PJ. Walls TJ. Newman PK. et al. Hashimoto's encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers-report of 5 cases. Neurology 1991:41:228-233.
2. Ghika-Schmid F. Ghika J. Regli F. et al. Hashimoto's myoclonic encephalopathy: an underdiagnosed treatable condition? Mov Disord 1996:11:555-562.
3. Fujii A. Yoneda M. Ito T. et al. Autoantibodies against the amino terminal of α-enolase are a useful diagnostic marker of Hashimoto's encephalopathy. J Neuroimmunol 2005:162:130-136.
4. Yoneda M. Fujii A. Ito A. et al. High prevalence of serum autoantibodies against the amino terminal of α-enolase in Hashimoto's encephalopathy. J Neuroimmunol 2007:185:195-200.
5. Brain Nerve 2008:60:559-565.
6. Clin Neurosci 2008:26:532-535.
7. Nakagawa H. Yoneda M. Fujii A. et al. Hashimoto's encephalopathy presenting with progressive cerebellar ataxia. J Neurol Neurosurg Psychiatry 2007:78:196-197.
8. Marshall GA. Dolye JJ. Long-term treatment of Hashimoto's encephalopathy. J Neurophsychiatr Clin Neurosci 2006:18:14-20.